New Bladder-Saving cancer treatment shows promise
NCT ID NCT05975307
Summary
This study is testing a treatment plan for muscle-invasive bladder cancer that aims to avoid major surgery. It combines chemotherapy, an immunotherapy drug (toripalimab), and radiation therapy to try to eliminate the cancer while preserving the patient's bladder. The main goals are to see if this combination is effective and safe for patients who are not good candidates for or wish to avoid bladder removal surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RADIOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Center, Sun Yat-sen University
Guangzhou, Guangdong, 510060, China
Conditions
Explore the condition pages connected to this study.